HSDT
Income statement / Annual
Last year (2023), Helius Medical Technologies, Inc.'s total revenue was $644,000.00,
a decrease of 18.17% from the previous year.
In 2023, Helius Medical Technologies, Inc.'s net income was -$8.85 M.
See Helius Medical Technologies, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
03/31/2015 |
03/31/2014 |
| Operating Revenue |
$644,000.00 |
$787,000.00 |
$522,000.00 |
$661,000.00 |
$1.50 M |
$478,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$583,000.00
|
$463,000.00
|
$298,000.00
|
$388,000.00
|
$846,000.00
|
$0.00
|
$0.00
|
$0.00
|
$171,781.00
|
$0.00
|
| Gross Profit |
$61,000.00
|
$324,000.00
|
$224,000.00
|
$273,000.00
|
$650,000.00
|
$478,000.00
|
$0.00
|
$0.00
|
-$171,781.00
|
$0.00
|
| Gross Profit Ratio |
0.09
|
0.41
|
0.43
|
0.41
|
0.43
|
1
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$2.94 M
|
$4.26 M
|
$5.99 M
|
$4.58 M
|
$8.06 M
|
$9.94 M
|
$14.39 M
|
$4.72 M
|
$3.83 M
|
$171,781.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$17.21 M
|
$8.47 M
|
$5.65 M
|
$4.26 M
|
$895,503.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$774,400.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.27 M
|
$10.64 M
|
$12.18 M
|
$9.71 M
|
$16.52 M
|
$17.21 M
|
$8.47 M
|
$5.65 M
|
$5.04 M
|
$895,503.00
|
| Other Expenses |
$276,000.00
|
$181,000.00
|
$200,000.00
|
$363,000.00
|
$64,000.00
|
$63,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$12.49 M
|
$15.08 M
|
$18.37 M
|
$14.66 M
|
$24.65 M
|
$27.15 M
|
$22.85 M
|
$10.37 M
|
$8.86 M
|
$1.07 M
|
| Cost And Expenses |
$13.07 M
|
$15.55 M
|
$18.66 M
|
$15.05 M
|
$25.49 M
|
$27.15 M
|
$22.85 M
|
$10.37 M
|
$8.86 M
|
$1.07 M
|
| Interest Income |
$0.00
|
$834,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$111,000.00
|
$20,074.00
|
$0.00
|
| Interest Expense |
$0.00
|
$834,000.00
|
$0.00
|
$0.00
|
$0.00
|
$1.95 M
|
$5.17 M
|
$1.67 M
|
$176,488.00
|
$0.00
|
| Depreciation & Amortization |
$162,000.00
|
$306,000.00
|
$374,000.00
|
$482,000.00
|
$191,000.00
|
$59,000.00
|
$17,000.00
|
$1.78 M
|
$20,074.00
|
$0.00
|
| EBITDA |
-$12.11 M |
-$14.50 M |
-$17.82 M |
-$13.90 M |
-$23.93 M |
-$26.62 M |
-$17.67 M |
-$8.60 M |
-$6.83 M |
-$1.07 M |
| EBITDA Ratio |
-18.8
|
-20.45
|
-34.39
|
-21.33
|
-25.35
|
-51.47
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-19.3
|
-18.75
|
-34.75
|
-21.76
|
-16.04
|
-55.81
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$3.58 M
|
$687,000.00
|
$10,000.00
|
$72,000.00
|
$14.22 M
|
-$1.95 M
|
-$5.17 M
|
-$1.67 M
|
$1.98 M
|
$0.00
|
| Income Before Tax |
-$8.85 M
|
-$14.07 M
|
-$18.13 M
|
-$14.13 M
|
-$9.78 M
|
-$28.62 M
|
-$28.02 M
|
-$12.04 M
|
-$8.89 M
|
-$1.07 M
|
| Income Before Tax Ratio |
-13.74
|
-17.88
|
-34.74
|
-21.38
|
-6.54
|
-59.88
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$1.51 M
|
-$10,000.00
|
-$193,000.00
|
-$14.12 M
|
$3.96 M
|
$10.34 M
|
$1.67 M
|
-$146,615.00
|
$0.00
|
| Net Income |
-$8.85 M
|
-$12.56 M
|
-$18.12 M
|
-$13.94 M
|
$4.34 M
|
-$28.62 M
|
-$28.02 M
|
-$12.04 M
|
-$8.89 M
|
-$1.07 M
|
| Net Income Ratio |
-13.74
|
-15.96
|
-34.72
|
-21.08
|
2.9
|
-59.88
|
0
|
0
|
0
|
0
|
| EPS |
-14.56 |
-46.52 |
-368.82 |
-581.8 |
288.15 |
-2198.39 |
-2632.1 |
0 |
-27.29 |
0 |
| EPS Diluted |
-14.56 |
-46.52 |
-368.82 |
-581.8 |
288.15 |
-2198.22 |
-2632.1 |
0 |
-27.29 |
0 |
| Weighted Average Shares Out |
$607,890.00
|
$269,943.00
|
$49,135.00
|
$23,955.00
|
$15,058.00
|
$13,020.00
|
$10,647.00
|
$0.00
|
$325,986.00
|
$0.00
|
| Weighted Average Shares Out Diluted |
$607,890.00
|
$269,943.00
|
$49,135.00
|
$23,955.00
|
$15,058.00
|
$13,021.00
|
$10,647.00
|
$0.00
|
$325,986.00
|
$0.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
